Abstract:Osteoporosis is a major concern worldwide and can be attributed to an imbalance between osteoblastic bone formation and osteoclastic bone resorption due to the natural aging process. Heritable factors account for 60–80% of optimal bone mineralization; however, the finer details of pathogenesis remain to be elucidated. Micro RNA (miRNA) and long-non-coding RNA (lncRNA) are two targets that have recently come into the spotlight due to their ability to control gene expression at the post-transcriptional level and provide epigenetic modification. miRNAs are a class of non-coding RNAs that are approximately 18–25 nucleotides long. It is thought that up to 60% of human protein-coding genes may be regulated by miRNAs. They have been found to regulate gene expression that controls osteoblast-dependent bone formation and osteoclast-related bone remodeling. lncRNAs are highly structured RNA transcripts longer than 200 nucleotides that do not translate into proteins. They have very complex secondary and tertiary structures and the same degradation processes as messenger RNAs. The fact that they have a rapid turnover is due to their sponge function in binding the miRNAs that lead to a degradation of the lncRNA itself. They can act as signaling, decoy, and framework molecules, or as primers. Current evidence suggests that lncRNAs can act as chromatin and transcriptional as well as post-transcriptional regulators. With regards to osteoporosis, lncRNA is thought to be involved in the proliferation, apoptosis, and inflammatory response of the bone. This review, which is based on a systematic appraisal of the current literature, provides current molecular and genetic opinions on the roles of miRNAs and lncRNAs in osteoporosis. Further research into the epigenetic modification and the regulatory roles of these molecules will bring us closer to potential disease-modifying treatment for osteoporosis. However, more issues regarding the detailed actions of miRNAs and lncRNAs in osteoporosis remain unknown and controversial and warrant future investigation.

LncRNA, Important Players in Bone Development and Disease.

LncRNA, Important Player in Bone Development and Disease

Lncrnas: Function and Mechanism in Cartilage Development, Degeneration, and Regeneration

Long non-coding RNAs in bone formation: Key regulators and therapeutic prospects

The Multiple Function of Long Noncoding RNAs in Osteosarcoma Progression, Drug Resistance and Prognosis.

Insights into the Roles of Lncrnas in Skeletal and Dental Diseases

Advances of long non-coding RNAs in osteoclast differentiation and osteoporosis

An Overview of Long Noncoding RNAs Involved in Bone Regeneration from Mesenchymal Stem Cells

Role of LncRNAs and CircRNAs in Bone Metabolism and Osteoporosis

Long non-coding RNAs in osteoporosis: from mechanisms of action to therapeutic potential

Long Noncoding RNA: Genomics and Relevance to Physiology.

The regulatory roles of long noncoding RNAs in osteoporosis

Lncrnas As A New Regulator Of Chronic Musculoskeletal Disorder

Research progress in the correlation between long non-coding RNAs and bone and joint disease

Long Noncoding RNA: Multiple Players in Gene Expression

lncRNAs: insights into their function and mechanics in underlying disorders.

A potential therapeutic drug for osteoporosis: prospect for osteogenic LncRNAs

Long Noncoding RNA: Its Physiological and Pathological Roles.

Epigenetic Regulation by Long Noncoding RNAs in Osteo-/Adipogenic Differentiation of Mesenchymal Stromal Cells and Degenerative Bone Diseases.

Insight into the Role of Long Non-coding RNAs during Osteogenesis in Mesenchymal Stem Cells.

The Role of Micro RNA and Long-Non-Coding RNA in Osteoporosis